Aimmune Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Aimmune Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USA

NASDAQ

AIMT

DUNS 057562771

FDA Filings

Device Company	Device	Date
VOWST Aimmune Therapeutics, Inc., Seres Therapeutics, Inc.	Prescription Medication	2024-07-13
Zenpep Aimmune Therapeutics, Inc.	Prescription Medication	2024-05-22
Zenpep Aimmune Therapeutics, Inc.	Prescription Medication	2024-03-15
Zenpep Aimmune Therapeutics, Inc.	Prescription Medication	2023-11-10
Zenpep Aimmune Therapeutics, Inc.	Prescription Medication	2023-10-21
VOWST Aimmune Therapeutics, Inc., Seres Therapeutics, Inc.	Prescription Medication	2023-05-05
Zenpep Aimmune Therapeutics, Inc.	Prescription Medication	2021-11-10
Zenpep Aimmune Therapeutics, Inc.	Prescription Medication	2021-01-01

Similar & Related FDA Registered Companies

• Seres Therapeutics, Inc.

Related Finance Registrations

NCAGE Code	8H6R2	AIMMUNE THERAPEUTICS, INC.
CAGE Code	8H6R2	AIMMUNE THERAPEUTICS, INC.
S.A.M. Registration	8H6R2 [57562771]	AIMMUNE THERAPEUTICS, INC.
SEC	0001631650	Aimmune Therapeutics, Inc. of DELAWARE